_version_ 1785152126623678464
author Fiorillo, Bianca
Roselli, Rosalinda
Finamore, Claudia
Biagioli, Michele
di Giorgio, Cristina
Bordoni, Martina
Conflitti, Paolo
Marchianò, Silvia
Bellini, Rachele
Rapacciuolo, Pasquale
Cassiano, Chiara
Limongelli, Vittorio
Sepe, Valentina
Catalanotti, Bruno
Fiorucci, Stefano
Zampella, Angela
author_facet Fiorillo, Bianca
Roselli, Rosalinda
Finamore, Claudia
Biagioli, Michele
di Giorgio, Cristina
Bordoni, Martina
Conflitti, Paolo
Marchianò, Silvia
Bellini, Rachele
Rapacciuolo, Pasquale
Cassiano, Chiara
Limongelli, Vittorio
Sepe, Valentina
Catalanotti, Bruno
Fiorucci, Stefano
Zampella, Angela
author_sort Fiorillo, Bianca
collection PubMed
description
format Online
Article
Text
id pubmed-10688166
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-106881662023-12-01 Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders” Fiorillo, Bianca Roselli, Rosalinda Finamore, Claudia Biagioli, Michele di Giorgio, Cristina Bordoni, Martina Conflitti, Paolo Marchianò, Silvia Bellini, Rachele Rapacciuolo, Pasquale Cassiano, Chiara Limongelli, Vittorio Sepe, Valentina Catalanotti, Bruno Fiorucci, Stefano Zampella, Angela ACS Omega American Chemical Society 2023-11-16 /pmc/articles/PMC10688166/ /pubmed/38046314 http://dx.doi.org/10.1021/acsomega.3c08464 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Fiorillo, Bianca
Roselli, Rosalinda
Finamore, Claudia
Biagioli, Michele
di Giorgio, Cristina
Bordoni, Martina
Conflitti, Paolo
Marchianò, Silvia
Bellini, Rachele
Rapacciuolo, Pasquale
Cassiano, Chiara
Limongelli, Vittorio
Sepe, Valentina
Catalanotti, Bruno
Fiorucci, Stefano
Zampella, Angela
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
title Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
title_full Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
title_fullStr Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
title_full_unstemmed Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
title_short Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
title_sort correction to “discovery of a novel class of dual gpbar1 agonists–rorγt inverse agonists for the treatment of il-17-mediated disorders”
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688166/
https://www.ncbi.nlm.nih.gov/pubmed/38046314
http://dx.doi.org/10.1021/acsomega.3c08464
work_keys_str_mv AT fiorillobianca correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT rosellirosalinda correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT finamoreclaudia correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT biagiolimichele correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT digiorgiocristina correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT bordonimartina correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT conflittipaolo correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT marchianosilvia correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT bellinirachele correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT rapacciuolopasquale correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT cassianochiara correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT limongellivittorio correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT sepevalentina correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT catalanottibruno correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT fioruccistefano correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders
AT zampellaangela correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders